ArticleFrontiers in medicine2025
Association of the ROX index with mortality in sepsis patients: a retrospective study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Value of the ROX Index for Mortality in Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study Using the MIMIC-IV Database.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to explore the association between the ROX index and clinical outcomes in patients with sepsis. Methods: Data were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, including adult sepsis patients admitted to the intensive care unit (ICU). The primary outcome was 28-day mortality, while secondary outcomes included 7-day and 14-day mortality, ICU mortality, ICU length of stay (LOS), and hospital LOS. Restricted cubic spline models and Cox regression models were used to assess the associations between the ROX Index and clinical outcomes. Results: A total of 23,502 sepsis patients were included, who were stratified into high (ROX ≥ 6.46) and low ROX (ROX < 6.46) strata using a data-derived threshold survival analysis. In the unadjusted model, the high ROX stratum exhibited a significantly lower risk of 28-day mortality (HR = 0.33, 95% CI: 0.31-0.35, Conclusion: In patients with sepsis, a higher ROX index is associated with significantly lower mortality rates and shorter ICU and hospital stays. However, the ROX index demonstrated moderate predictive accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.